Selected research
Industry Growth & Trends
Global In Vitro Cytotoxicity Testing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global In Vitro Cytotoxicity Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for In Vitro Cytotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for In Vitro Cytotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for In Vitro Cytotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the In Vitro Cytotoxicity Testing Service market include Eurofins, SGS, Sartorius, UL, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global In Vitro Cytotoxicity Testing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The In Vitro Cytotoxicity Testing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global In Vitro Cytotoxicity Testing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to In Vitro Cytotoxicity Testing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global In Vitro Cytotoxicity Testing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
In Vitro Cytotoxicity Testing Service Market by Company
Eurofins
SGS
Sartorius
UL
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
TÜV SÜD
Medicilon
Huatongwei
In Vitro Cytotoxicity Testing Service Segment by Type
MTT Assay Method
LDH Assay Method
Neutral Red Uptake Assay Method
Others
In Vitro Cytotoxicity Testing Service Segment by Application
Drug
Medical Instruments
Cosmetics and Personal Care
Others
In Vitro Cytotoxicity Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Cytotoxicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Cytotoxicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Cytotoxicity Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of In Vitro Cytotoxicity Testing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- MTT Assay Method
- LDH Assay Method
- Neutral Red Uptake Assay Method
- Others
Applications
- Drug
- Medical Instruments
- Cosmetics and Personal Care
- Others
Companies covered
- Eurofins
- SGS
- Sartorius
- UL
- Emery Pharma
- Nelson Labs
- UFAG Laboratorien AG
- Pacific BioLabs
- NorthEast BioLab
- Biosafe Ltd
- Creative Bioarray
- Evercyte
- IONTOX
- Applied StemCell
- Xenometrix AG
- TÜV SÜD
- Medicilon
- Huatongwei
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global In Vitro Cytotoxicity Testing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global In Vitro Cytotoxicity Testing Service Market Size by Region (2021-2032)
- 1.4.1 Global In Vitro Cytotoxicity Testing Service Market Size by Region (2021-2026)
- 1.4.2 Global In Vitro Cytotoxicity Testing Service Market Size by Region (2027-2032)
- 1.5 Key Regions In Vitro Cytotoxicity Testing Service Market Size (2021-2032)
- 1.5.1 North America In Vitro Cytotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe In Vitro Cytotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America In Vitro Cytotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size Growth Rate (2021-2032)
2 In Vitro Cytotoxicity Testing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 MTT Assay Method
- 2.1.2 LDH Assay Method
- 2.1.3 Neutral Red Uptake Assay Method
- 2.1.4 Others
- 2.2 Global In Vitro Cytotoxicity Testing Service Market Size by Type
- 2.2.1 Global In Vitro Cytotoxicity Testing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global In Vitro Cytotoxicity Testing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global In Vitro Cytotoxicity Testing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global In Vitro Cytotoxicity Testing Service Market Size by Regions
- 2.3.1 North America In Vitro Cytotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe In Vitro Cytotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America In Vitro Cytotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa In Vitro Cytotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
3 In Vitro Cytotoxicity Testing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug
- 3.1.2 Medical Instruments
- 3.1.3 Cosmetics and Personal Care
- 3.1.4 Others
- 3.2 Global In Vitro Cytotoxicity Testing Service Market Size by Application
- 3.2.1 Global In Vitro Cytotoxicity Testing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global In Vitro Cytotoxicity Testing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global In Vitro Cytotoxicity Testing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global In Vitro Cytotoxicity Testing Service Market Size by Regions
- 3.3.1 North America In Vitro Cytotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe In Vitro Cytotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America In Vitro Cytotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa In Vitro Cytotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 In Vitro Cytotoxicity Testing Service Industry Trends
- 4.2 In Vitro Cytotoxicity Testing Service Industry Drivers
- 4.3 In Vitro Cytotoxicity Testing Service Industry Opportunities and Challenges
- 4.4 In Vitro Cytotoxicity Testing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by In Vitro Cytotoxicity Testing Service Revenue (2021-2026)
- 5.2 Global In Vitro Cytotoxicity Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global In Vitro Cytotoxicity Testing Service Key Company Headquarters & Area Served
- 5.4 Global In Vitro Cytotoxicity Testing Service Company, Product Type & Application
- 5.5 Global In Vitro Cytotoxicity Testing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global In Vitro Cytotoxicity Testing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 In Vitro Cytotoxicity Testing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 In Vitro Cytotoxicity Testing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eurofins
- 6.1.1 Eurofins Company Information
- 6.1.2 Eurofins Business Overview
- 6.1.3 Eurofins In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eurofins In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.1.5 Eurofins Recent Developments
- 6.2 SGS
- 6.2.1 SGS Company Information
- 6.2.2 SGS Business Overview
- 6.2.3 SGS In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 SGS In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.2.5 SGS Recent Developments
- 6.3 Sartorius
- 6.3.1 Sartorius Company Information
- 6.3.2 Sartorius Business Overview
- 6.3.3 Sartorius In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sartorius In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.3.5 Sartorius Recent Developments
- 6.4 UL
- 6.4.1 UL Company Information
- 6.4.2 UL Business Overview
- 6.4.3 UL In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 UL In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.4.5 UL Recent Developments
- 6.5 Emery Pharma
- 6.5.1 Emery Pharma Company Information
- 6.5.2 Emery Pharma Business Overview
- 6.5.3 Emery Pharma In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Emery Pharma In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.5.5 Emery Pharma Recent Developments
- 6.6 Nelson Labs
- 6.6.1 Nelson Labs Company Information
- 6.6.2 Nelson Labs Business Overview
- 6.6.3 Nelson Labs In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Nelson Labs In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.6.5 Nelson Labs Recent Developments
- 6.7 UFAG Laboratorien AG
- 6.7.1 UFAG Laboratorien AG Company Information
- 6.7.2 UFAG Laboratorien AG Business Overview
- 6.7.3 UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.7.5 UFAG Laboratorien AG Recent Developments
- 6.8 Pacific BioLabs
- 6.8.1 Pacific BioLabs Company Information
- 6.8.2 Pacific BioLabs Business Overview
- 6.8.3 Pacific BioLabs In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Pacific BioLabs In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.8.5 Pacific BioLabs Recent Developments
- 6.9 NorthEast BioLab
- 6.9.1 NorthEast BioLab Company Information
- 6.9.2 NorthEast BioLab Business Overview
- 6.9.3 NorthEast BioLab In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 NorthEast BioLab In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.9.5 NorthEast BioLab Recent Developments
- 6.10 Biosafe Ltd
- 6.10.1 Biosafe Ltd Company Information
- 6.10.2 Biosafe Ltd Business Overview
- 6.10.3 Biosafe Ltd In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Biosafe Ltd In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.10.5 Biosafe Ltd Recent Developments
- 6.11 Creative Bioarray
- 6.11.1 Creative Bioarray Company Information
- 6.11.2 Creative Bioarray Business Overview
- 6.11.3 Creative Bioarray In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Creative Bioarray In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.11.5 Creative Bioarray Recent Developments
- 6.12 Evercyte
- 6.12.1 Evercyte Company Information
- 6.12.2 Evercyte Business Overview
- 6.12.3 Evercyte In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Evercyte In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.12.5 Evercyte Recent Developments
- 6.13 IONTOX
- 6.13.1 IONTOX Company Information
- 6.13.2 IONTOX Business Overview
- 6.13.3 IONTOX In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 IONTOX In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.13.5 IONTOX Recent Developments
- 6.14 Applied StemCell
- 6.14.1 Applied StemCell Company Information
- 6.14.2 Applied StemCell Business Overview
- 6.14.3 Applied StemCell In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Applied StemCell In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.14.5 Applied StemCell Recent Developments
- 6.15 Xenometrix AG
- 6.15.1 Xenometrix AG Company Information
- 6.15.2 Xenometrix AG Business Overview
- 6.15.3 Xenometrix AG In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Xenometrix AG In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.15.5 Xenometrix AG Recent Developments
- 6.16 TÜV SÜD
- 6.16.1 TÜV SÜD Company Information
- 6.16.2 TÜV SÜD Business Overview
- 6.16.3 TÜV SÜD In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 TÜV SÜD In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.16.5 TÜV SÜD Recent Developments
- 6.17 Medicilon
- 6.17.1 Medicilon Company Information
- 6.17.2 Medicilon Business Overview
- 6.17.3 Medicilon In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Medicilon In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.17.5 Medicilon Recent Developments
- 6.18 Huatongwei
- 6.18.1 Huatongwei Company Information
- 6.18.2 Huatongwei Business Overview
- 6.18.3 Huatongwei In Vitro Cytotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Huatongwei In Vitro Cytotoxicity Testing Service Product Portfolio
- 6.18.5 Huatongwei Recent Developments
7 North America
- 7.1 North America In Vitro Cytotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
- 7.3 North America In Vitro Cytotoxicity Testing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe In Vitro Cytotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
- 8.3 Europe In Vitro Cytotoxicity Testing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America In Vitro Cytotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
- 10.3 South America In Vitro Cytotoxicity Testing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst